Thymoquinone inhibits the CXCL12-induced chemotaxis of multiple myeloma cells and increases their susceptibility to Fas-mediated apoptosis.
In multiple myeloma (MM), malignant plasma cells reside in the bone marrow, where they accumulate in close contact with stromal cells. The mechanisms responsible for the chemotaxis of malignant plasma cells are still poorly understood. Thus, we investigated the mechanisms involved in the chemotaxis...
Main Authors: | Gamal Badr, Eric A Lefevre, Mohamed Mohany |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3164673?pdf=render |
Similar Items
-
Effects of undenatured whey protein supplementation on CXCL12- and CCL21-mediated B and T cell chemotaxis in diabetic mice
by: Badr Gamal, et al.
Published: (2011-11-01) -
Thymoquinone decreases F-actin polymerization and the proliferation of human multiple myeloma cells by suppressing STAT3 phosphorylation and Bcl2/Bcl-<sub>XL </sub>expression
by: Badr Gamal, et al.
Published: (2011-12-01) -
Regulation of T cell chemotaxis by CXCL4
by: Petersen F, et al.
Published: (2009-02-01) -
CXCL12-stimulated lymphocytes produce secondary stimulants that affect the surrounding cell chemotaxis
by: Kaoru Kurowarabe, et al.
Published: (2021-12-01) -
2-Arachidonoylglycerol Modulates CXCL12-Mediated Chemotaxis in Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia
by: Magali Merrien, et al.
Published: (2023-03-01)